Development of novel CAR-T therapy technology targeting novel cancer antigen
Development of CAR-T therapy technology improving medicinal effect
Development of CAR-T therapy technology improving existing side effects
Development of CAR-T therapy technology automating quality analysis
Jong Ran Kim
Head of Clinical Development Center
Executive Vice President
Head of Clinical Development Center
ABL Bio Executive Vice President, Clinical Devopment Team
Samsung Bioepis Vice President, Clinical Devopment Team
ICON APAC Vice President, Clin Ops – APAC
Eli Lilly, Regional Manager – Asia
Master of Science, Genetic Engineering, Korea University
Hyeun Jin Seo
Director
Regulatory Affairs
Clinical Project Management
ChongKunDang Product/Bio development Senior Manager
Hanhwa Solution Regulatory Affairs Senior Manager
Mi Kyung Kim, Ph.D.
Director
External R&D
Director
Molecular Biology Mechanism Study
Professor of Biology at Yonsei Univ.
Post Doc., NYC Medical Center / Ph.D. of Biology, Yonsei Univ.
Hyerim Kang
Director
Managing Director of Clinical Project Management
Director
Clinical Project Manager
Samsung Bioepis Lucentis/Eylea Biosimilar Global Clinical Program Director
UCB Clinical Project Management Director
IQVIA Asia Reginal start-up Lead
Roche Clinical Vendor Manager
Changwan Hong, Ph.D.
Associate professor, Department of Anatomy, PNU School of Medicine
Outside director
Ph.D., Cellular Immunology, Korea University
Chairman, Department of Convergence Medical Science, PNU School of Medicine
Suhee Cho
Director
Clinical development Advisor
Clinical development advisor
Gyeongsang National Univ. department of Hemato-oncology
Pusan National University Yangsan Hospital Clinical assistant professor
Daniel Ryu
Law office Cheongdang Partner Attorney
Auditor
Boston Univ. Law School
Jin Kyong Park
Chief Financial Officer
CFO / Director
LG Chemical R&D Strategic Planning
Chungnam national Univ. department of Business Administration
Hyun-Bo Sim, Ph.D.
Ewha Womans University Associate Professor of department of Bioinspired Science
Professor of EHWA Womans Univ.
XOMA Corp., a therapeutic antibody development / Researcher
SCRIPPS Laboratory, Humanized Antibody Discovery / Post Doc
Master of Chemistry, Seoul National Univ. / Dr. Texas A&M University, USA
Gunsoo Kim
CEO
Chief Executive Officer
LG Chem. R&D, strategic planning 20 years
CHABiotech research planning
M.A. of Biotechnology, Yonsei University
Hyeong Cheol Kim, Ph.D
Executive Director
Head of R&D Center
Head of Technical Research Institute(R&D Center)
15 years of R&D experience, responsible for LG Chemistry’s biosimilar development
Ph. D., Univ. of Texas at Austin / Department of Microbiology, Seoul National Univ.
Chanhyuk Kim, Ph.D.
KAIST Assistant Professor of Department of Life Sciences
Professor of KAIST
California Institute for Biomedical Research, Synthetic immunodynamics / PI
Post Doc., The Scripps Research Institute / Ph. D. of Chemistry, Seoul National Univ.
Jung Hee Lim
Intervest Executive Director
We pursue a corporate culture that values and nurtures human resources. We aim for a company that pushes and attracts, and values communication and feedback.
Although it is a very difficult time because of COVID-19, Qurocell will do its best to showcase technologies that can contribute to the country and even the world.